Alpha IVF Group Berhad (KLSE:ALPHA)

Market Cap	1.46B
Revenue (ttm)	185.94M
Net Income (ttm)	58.35M
Shares Out	4.86B
EPS (ttm)	0.01
PE Ratio	25.03
Forward PE	21.43
Dividend	0.01 (3.33%)
Ex-Dividend Date	Aug 8, 2025

Volume	2,316,600
Average Volume	1,771,235
Open	0.3050
Previous Close	0.3050
Day's Range	0.2950 - 0.3050
52-Week Range	0.2650 - 0.3450
Beta	n/a
RSI	38.64
Earnings Date	Jan 27, 2026

About Alpha IVF Group Berhad

Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation op...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2011
• Employees: 198
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: ALPHA

Financial Performance

In 2025, Alpha IVF Group Berhad's revenue was 176.84 million, an increase of 5.52% compared to the previous year's 167.59 million. Earnings were 57.45 million, an increase of 8.54%.